American Liver Foundation gears up for advocacy summit
Patients, caregivers, and supporters will head to Washington later this month to advocate for policies to improve life for people living with fatty liver…
Liver cancer
Phase 1 trial of CAR T-cell therapy for liver cancer announced
Eureka Therapeutics and City of Hope will jointly conduct a Phase 1 clinical trial of assessing Eureka’s investigational CAR T-cell therapy ET1402 for hepatocellular carcinoma (HCC), the most…
SIR-Spheres Radiation Microspheres Outperform Chemo in Liver Cancer Trial
SIR-Spheres radiation microspheres shrank the tumors of a significantly larger number of liver cancer patients than Nexavar in a Phase 3 trial.
Digital Support Platform IO Loop Keeps Oncologists and Patients Engaged Throughout Treatment
A new digital support platform, IO Loop, is helping patients stay connected online with doctors before, during, and after treatment. This helps patients track symptoms,…
Drinking More Coffee Can Reduce Risk of Hepatocellular Carcinoma, Scottish Study Finds
Coffee consumption can dramatically cut one’ risk of developing hepatocellular carcinoma (HCC), a type of liver cancer, say researchers from Scotland’s University of Edinburgh who…
FDA Grants Priority Review Status to Opdivo Application for Advanced Liver Cancer Patients
The U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) submitted by Bristol-Myers Squibb seeking approval for Opdivo…
SIR-Spheres Radiation Therapy Increases Chance Liver Cancer Can Be Operated on, Study Reports
Those with liver cancer that has spread from the colon have a better chance of surgical removal of their liver tumors after treatment with…
New ‘Liver Line’ Online Community to Share Updates on Health, Research, Treatments
A new online community, called Liver Line and sponsored by Galectin Therapeutics, offers the latest information on liver health and research into liver diseases. On Liver…
Can-Fite’s Namodenoson to Enter NAFLD/NASH Phase 2 Clinical Trial
Can-Fite BioPharma has concluded preparations for its Phase 2 trial evaluating namodenoson (CF102) for the treatment of non-alcoholic fatty liver disease (NAFLD). The study will…
Singapore Researchers Develop Probe That Improves Liver Cancer MRI Imaging
Researchers at the National University of Singapore have developed a probe that provides doctors with clearer and more accurate magnetic resonance images of liver cancer.
